Health Dictionary Find a Doctor

Autoimmune polyendocrine syndrome history and symptoms

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

Overview

A detailed history may be helpful in the early diagnosis of the autoimmune polyendocrine syndrome (APS). Autoimmune polyendocrine syndrome patients generally have an early onset. In such cases, history from the caregivers may be obtained. An important aspect involves obtaining family history about the presence of APS in family members since APS can be transmitted in genetic mode. Patients with the autoimmune polyendocrine syndrome (APS) have varied symptoms depending on the subtype. The most common presentation of APS-1 include mucocutaneous candidiasis, hypoparathyroidism and Addison’s disease. The most common presentation of APS-2 include Addison’s disease with autoimmune thyroiditis or diabetes mellitus type 1. The most common presentation of APS 3 include autoimmune thyroiditis, diabetes mellitus type 1, pernicious anemia and/or with involvement of a non-endocrine organ.

History

History

Obtaining a detailed history is an important aspect in making a diagnosis of autoimmune polyendocrine syndrome (APS). It provides insight into the cause, precipitating factors and associated comorbid conditions. It also helps in determining the correct therapy and the prognosis. Autoimmune polyendocrine syndrome patients generally have an early onset. In such cases history from the care givers or the family members may need to be obtained. Specific areas of focus while obtaining history, are outlined below:[1][2][3]

Symptoms

Symptoms

Patients with autoimmune polyendocrine syndrome (APS) have varied symptoms depending upon the subtype.

Autoimmune polyendocrine syndrome (APS) type 1

APS type 1 commonly presents in infancy. The symptoms include:[4][5][6][7][8][9]

Autoimmune polyendocrine syndrome (APS) type 2

APS type 2 commonly presents in infancy and adulthood. The symptoms include:[10][11][12]

Autoimmune polyendocrine syndrome (APS) type 3

APS type 3 commonly presents in neonatal period. The symptoms include:[13][14][15]

References

References

  1. De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Chrousos, Charmandari E. PMID 25905309. Missing or empty |title= (help)
  2. Halonen M, Eskelin P, Myhre AG, Perheentupa J, Husebye ES, Kämpe O, Rorsman F, Peltonen L, Ulmanen I, Partanen J (2002). “AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype”. J. Clin. Endocrinol. Metab. 87 (6): 2568–74. doi:10.1210/jcem.87.6.8564. PMID 12050215.
  3. Borgaonkar MR, Morgan DG (1999). “Primary biliary cirrhosis and type II autoimmune polyglandular syndrome”. Can. J. Gastroenterol. 13 (9): 767–70. PMID 10633830.
  4. Weiler FG, Dias-da-Silva MR, Lazaretti-Castro M (2012). “Autoimmune polyendocrine syndrome type 1: case report and review of literature”. Arq Bras Endocrinol Metabol. 56 (1): 54–66. PMID 22460196.
  5. Joshi RR, Rao S, Prabhu SS (2006). “Polyglandular autoimmune syndrome-type I”. Indian Pediatr. 43 (12): 1085–7. PMID 17202607.
  6. Kahaly GJ (2009). “Polyglandular autoimmune syndromes”. Eur. J. Endocrinol. 161 (1): 11–20. doi:10.1530/EJE-09-0044. PMID 19411300.
  7. Charmandari E, Nicolaides NC, Chrousos GP (2014). “Adrenal insufficiency”. Lancet. 383 (9935): 2152–67. doi:10.1016/S0140-6736(13)61684-0. PMID 24503135.
  8. Ahonen P, Myllärniemi S, Sipilä I, Perheentupa J (1990). “Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients”. N. Engl. J. Med. 322 (26): 1829–36. doi:10.1056/NEJM199006283222601. PMID 2348835.
  9. Betterle C, Greggio NA, Volpato M (1998). “Clinical review 93: Autoimmune polyglandular syndrome type 1”. J. Clin. Endocrinol. Metab. 83 (4): 1049–55. doi:10.1210/jcem.83.4.4682. PMID 9543115.
  10. Cyniak-Magierska A, Lasoń A, Smyczyńska J, Lewiński A (2015). “Autoimmune polyglandular syndrome type 2 manifested as Hashimoto’s thyroiditis and adrenocortical insufficiency, in Turner syndrome woman, with onset following introduction of treatment with recombinant human growth hormone”. Neuro Endocrinol. Lett. 36 (2): 119–23. PMID 26071578.
  11. Betterle C, Dal Pra C, Mantero F, Zanchetta R (2002). “Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction”. Endocr. Rev. 23 (3): 327–64. doi:10.1210/edrv.23.3.0466. PMID 12050123.
  12. Majeroni BA, Patel P (2007). “Autoimmune polyglandular syndrome, type II”. Am Fam Physician. 75 (5): 667–70. PMID 17375512.
  13. Shimomura H, Nakase Y, Furuta H, Nishi M, Nakao T, Hanabusa T, Sasaki H, Okamoto K, Furukawa F, Nanjo K (2003). “A rare case of autoimmune polyglandular syndrome type 3”. Diabetes Res. Clin. Pract. 61 (2): 103–8. PMID 12951278.
  14. Oki K, Yamane K, Koide J, Mandai K, Nakanishi S, Fujikawa R, Kohno N (2006). “A case of polyglandular autoimmune syndrome type III complicated with autoimmune hepatitis”. Endocr. J. 53 (5): 705–9. PMID 16946565.
  15. Sheehan MT, Islam R (2009). “Silent thyroiditis, isolated corticotropin deficiency, and alopecia universalis in a patient with ulcerative colitis and elevated levels of plasma factor VIII: an unusual case of autoimmune polyglandular syndrome type 3”. Endocr Pract. 15 (2): 138–42. doi:10.4158/EP.15.2.138. PMID 19289325.

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH